HealthEquity, Inc. (NASDAQ:HQY – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the thirteen ratings firms that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, eleven have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price target among brokerages that have covered the stock in the last year is $113.53.
A number of equities analysts recently weighed in on the stock. Telsey Advisory Group set a $111.00 price objective on shares of HealthEquity in a report on Friday, August 28th. Raymond James Financial reiterated a “strong-buy” rating on shares of HealthEquity in a research note on Thursday, September 3rd. BMO Capital Markets lifted their target price on HealthEquity from $105.00 to $125.00 and gave the stock an “outperform” rating in a report on Wednesday, October 21st. Citigroup reissued a “market outperform” rating on shares of HealthEquity in a report on Friday, August 28th. Finally, BTIG Research restated a “buy” rating and issued a $115.00 price target on shares of HealthEquity in a research note on Friday, August 28th.
Get Our Latest Research Report on HQY
Insider Activity at HealthEquity
Hedge Funds Weigh In On HealthEquity
A number of hedge funds have recently bought and sold shares of the business. Axiom Investment Management LLC purchased a new stake in shares of HealthEquity during the 1st quarter valued at about $33,000. Silvant Capital Management LLC bought a new stake in shares of HealthEquity in the second quarter worth approximately $35,000. Public Employees Retirement System of Ohio bought a new stake in shares of HealthEquity in the second quarter worth approximately $39,000. International Assets Investment Management LLC grew its stake in shares of HealthEquity by 18,333.3% in the first quarter. International Assets Investment Management LLC now owns 553 shares of the company’s stock worth $46,000 after acquiring an additional 550 shares during the period. Finally, Jacobi Capital Management LLC purchased a new position in shares of HealthEquity during the third quarter valued at approximately $48,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.
HealthEquity Stock Performance
Shares of HealthEquity stock opened at $103.46 on Wednesday. HealthEquity has a 1 year low of $72.76 and a 1 year high of $110.26. The firm’s 50-day moving average is $96.08 and its 200 day moving average is $89.97. The stock has a market cap of $8.56 billion, a price-to-earnings ratio of 37.35, a PEG ratio of 1.63 and a beta of 0.22. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.99 and a quick ratio of 2.99.
HealthEquity (NASDAQ:HQY – Get Free Report) last issued its earnings results on Thursday, August 27th. The company reported $1.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.19 by $0.05. HealthEquity had a net margin of 17.36% and a return on equity of 15.33%. The business had revenue of $350.73 million during the quarter, compared to analysts’ expectations of $349.22 million. The firm’s revenue for the quarter was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. Sell-side analysts anticipate that HealthEquity will post 3.94 EPS for the current fiscal year.
HealthEquity Company Profile
HealthEquity, Inc. provides technology and services for health savings accounts (HSAs) and other consumer-directed benefits. Its platform supports employers, health plans, benefits advisers and individuals in managing health-related accounts and benefits. Alongside HSAs, the company administers flexible spending accounts, health reimbursement arrangements, commuter benefits and other workplace benefit programs. Its services include account administration, payment tools, customer support and investment options for eligible HSA funds.
Further Reading
- Five stocks we like better than HealthEquity
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
